Navigation Links
Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions
Date:10/9/2008

SOUTHAMPTON, Pa., Oct. 9 /PRNewswire-FirstCall/ -- Environmental Tectonics Corporation's (Amex: ETC) ("ETC" or the "Company") BioMedical Division today announced the sale of three (3) additional BARA-MED(R) XD Monoplace Hyperbaric Chambers to Comprehensive Healthcare Solutions, Inc.

Comprehensive Healthcare Solutions, a growing company who focuses solely on initiating and operating Wound Healing Institutes throughout the United States, has purchased a total of five (5) BARA-MED(R) XD chambers from ETC within the last ten month period.

Mario Caruso, CHT, DMT-A, Technical Director, Hyperbaric Services for Comprehensive Healthcare Solutions, remarked, "We strive to be at the cutting edge of advances in wound care and hyperbaric medicine. ETC's BARA-MED(R) XD monoplace chamber has features, like computer control, programmable curvilinear descent, and more. The employment of these advanced components, make it the hyperbaric chamber of choice for us."

ETC is the only manufacturer of a 4th generation, time-honored computerized monoplace hyperbaric chamber. The BARA-MED(R) XD includes O.S.C.A.R. (TM) (Operating System for Control And Recordkeeping).

With O.S.C.A.R. (TM), you eliminate the need for operator dive time management and paper recordkeeping while ensuring comprehensive documentation of the procedure. These features enable technicians to focus their attention on patient care and management, making your team more effective and efficient.

ETC manufactures the industry's most technically advanced hyperbaric chamber. ETC chambers remain the leader in providing a patient friendly pressurization alternative (Smooth Ride(TM)) that minimizes complications due to middle ear and sinus barotraumas without increasing compression time.

Gene Davis, President of ETC's BioMedical Division, commented, "We are delighted with the growth we have experienced this fiscal year. Sales are at an all time high."

ETC's BioMedical Systems Division's goal is to continue to be at the forefront of hyperbaric medicine and EMR with O.S.C.A.R. (TM).

ETC designs, develops, installs and maintains aircrew training systems (aeromedical, tactical combat and general), disaster management training systems and services, entertainment products, sterilizers (steam and gas), environmental testing products, hyperbaric chambers and related products for domestic and international customers.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on ETC's current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about ETC's and its subsidiaries that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

These forward-looking statements include statements with respect to the Company's vision, mission, strategies, goals, beliefs, plans, objectives, expectations, anticipations, estimates, intentions, financial condition, results of operations, future performance and business of the company, including but not limited to, (i) the potential delisting of the Company's common stock from the American Stock Exchange as a result of the Company's failure to comply with the AMEX listing standards, (ii) projections of revenues, costs of materials, income or loss, earnings or loss per share, capital expenditures, growth prospects, dividends, capital structure, other financial items and the effects of currency fluctuations, (iii) statements of our plans and objectives of the Company or its management or Board of Directors, including the introduction of new products, or estimates or predictions of actions of customers, suppliers, competitors or regulatory authorities, (iv) statements of future economic performance, (v) statements of assumptions and other statements about the Company or its business, (vi) statements made about the possible outcomes of litigation involving the Company, including our outstanding litigation with Disney; (vii) statements regarding the Company's ability to obtain financing to support its operations and other expenses, and (viii) statements preceded by, followed by or that include the words, "may," "could," "should," "looking forward," "would," "believe," "expect," "anticipate," "estimate," "intend," "plan," or the negative of such terms or similar expressions. These forward-looking statements involve risks and uncertainties which are subject to change based on various important factors. Some of these risks and uncertainties, in whole or in part, are beyond the Company's control. Factors that might cause or contribute to such a material difference include, but are not limited to, those discussed in the Company's Annual Report on Form 10-K for the fiscal year ended February 29, 2008, in the section entitled "Risks Particular to Our Business." Shareholders are urged to review these risks carefully prior to making an investment in the Company's common stock.

The Company cautions that the foregoing list of important factors is not exclusive. Except as required by federal securities law, the Company does not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by or on behalf of the Company.

Contact: Duane D. Deaner, CFO

Tel: 215-355-9100 (ext. 1203)

Fax: 215-357-4000

ETC - Internet Home Page: http://www.etcusa.com


'/>"/>
SOURCE Environmental Tectonics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Environmental Tectonics Corporation Announces the Placement of Two Monoplace Hyperbaric Chambers at Saint Barnabas Medical Center in New Jersey
2. Bion Announces Approval of New Australian Patent for Low Oxygen Organic Waste Bioconversion for Livestock Waste Environmental Treatment
3. Environmental Tectonics Corporation Announces a Multiple Sale for Monoplace Hyperbaric Chambers
4. Environmental Tectonics Corporations Sterilization Systems Group Announces New Contracts
5. Bion Announces Approval of New U.S. Patent for Phosphorus Removal Process for Livestock Waste Environmental Treatment
6. Carbon hoofprint: Cows supplemented with rbST reduce agricultures environmental impact
7. Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters
8. Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates
9. Environmental Tectonics Corporations BioMedical Systems Division Awarded Contract for Multiple Monoplace Chambers
10. Environmental Tectonics Corporations BioMedical Division Announces Sale of Two Hyperbaric Chambers
11. Startech Environmental to Have Three Plasma Converters in Former Pharmaceutical Industry Facility in Puerto Rico
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):